The Neuroblastoma Childrens Cancer
PeerBasis did not identify a benchmark-executive compensation figure for The Neuroblastoma Childrens Cancer in its current latest-filed snapshot; this does not mean the organization reported no executive compensation.
Review the available peer set
Peer data are available for The Neuroblastoma Childrens Cancer. Open the preview and enter the 2025-dollar compensation amount the board is evaluating before preparing a report.
Open the previewSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.67–1.5× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Get The Medications Right Institute | VA | $29,927 | $19,595 |
| Snyder-robinson Foundation | VA | $28,210 | $164,982 |
| Pacific Endodontic Research Foundation | CA | $28,179 | $18,955 |
| Research Nebraska Inc | NE | $28,161 | $11,886 |
| Radiation And Public Health Projectinc | NJ | $32,312 | $45,279 |
| University Health Care Inc | WI | $33,940 | $1,101,388 |
| Genetic Resource Association Of Texas | TX | $23,084 | $1,699 |
| Urology Research & Education Foundation | TX | $38,637 | $24,134 |
View the organization record and available filings on ProPublica